SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

11 May 2022 07:00

RNS Number : 0217L
TP ICAP Group PLC
11 May 2022
 

TP ICAP Group plc ("TP ICAP" or the "Group")

 

11 May 2022

 

Trading update for the three months ended 31 March 2022

 

Highlights

· Group revenue, excluding Liquidnet, up 3% in constant currency. Including Liquidnet, Group revenue up 14%; growth across all business divisions;

· Varied market conditions: Higher level of volatility and trading activity in January / first half of March; more subdued volumes in February and later in March;

· We again increased overall market share during the first quarter;

· Better revenue mix: growth across all Global Broking asset classes other than Equities (unchanged);

· Global Broking revenue per broker up 8%;

· Data & Analytics again delivered double-digit revenue growth;

· Good progress on transformation programme: TP Interest Rate Options desk now has #2 market share (from #4), benefiting from Fusion deployment.

 

Revenue by division

 

Three months to31 March

 

 

2022

£m

2021 as reported £m

2021 in constant currency £m

Reported change

Constant currency change

Global Broking

317

306

309

 

Inter-division revenues1

5

5

5

 

Total Global Broking

322

311

314

+4%

+3%

Energy & Commodities

106

100

101

 

Inter-division revenues1

1

1

1

 

Total Energy & Commodities

107

101

102

+6%

+5%

Excluding Liquidnet

27

27

27

0%

0%

Liquidnet2

62

8

8

+675%

+675%

Total Agency Execution

89

35

35

+154%

+154%

Data & Analytics

40

36

36

+11%

+11%

Post-trade Solutions

4

6

6

-33%

-33%

Total Parameta Solutions

44

42

42

+5%

+5%

Inter-division eliminations1

(6)

(6)

(6)

 

Total Revenue

556

483

487

+15%

+14%

Total Revenue (excl. Liquidnet)

494

475

479

+4%

+3%

 

1. Inter-division charges have been made by Global Broking and Energy & Commodities to reflect the value of proprietary data provided to the Parameta Solutions division. The Global Broking inter-division revenues and Parameta Solutions inter-division costs are eliminated upon the consolidation of the Group's financial results.

2. In Q1 2021, £6m of revenue was included within Agency Execution relating to the post-acquisition period of Liquidnet (the acquisition completed on 23 March 2021); This Liquidnet revenue has been restated to £8m by including an additional £1m of revenue previously reported in Global Broking, and £1m previously reported in COEX Partners (in Agency Execution), reflecting the transfer of desks, which, due to their complementary nature and strategic fit, have been reclassified to be managed and reported as part of Liquidnet.

 

Revenue by division (constant currency basis):

· Global Broking revenue up 3%, benefitting from increased market volatility. Revenue grew in Rates, Credit, FX & Money Markets and Emerging Markets, but was flat in Equities, resulting in an improved mix.

Rates activity increased most notably in short-dated contracts, which have lower transaction values compared with longer-dated contracts;

Revenue per broker (productivity) improved by 8%.

· Energy & Commodities revenue up 5% driven by growth in Oil and Power & Gas in the US, while in Europe, Power & Gas declined, as high prices and significant volatility led to lower volumes.

· Agency Execution revenue of £89m increased by 154%. Liquidnet revenue of £62m was in line with market activity. Market share increased marginally in the US and was stable in Europe, where we remain a market leader.

· Parameta Solutions: Continued double-digit revenue growth in Data & Analytics (+11%).

 

Strategic progress

· Mark Govoni, former President of US Brokerage at Instinet, joined the Group on 2 May 2022 as the new CEO of Agency Execution, with a primary focus on driving the Liquidnet growth strategy;

· Parameta Solutions became an FCA authorised benchmark administrator in May: the first inter-dealer broker that will administer over the counter ('OTC') benchmarks;

· Digital Assets Spot Platform: Hudson River Trading added to the list of market makers; custodian network expanded to include BitGo and Komainu.

2022 AGM:

· The Group will host its Annual General Meeting today, Wednesday 11 May 2022, at 2.15pm (BST) at the offices of Allen & Overy LLP, One Bishop's Square, London, E1 6AD.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

 

Enquiries:

Analysts and investors Dominic LaganDirect: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com

Media Richard NewmanDirect: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

 

 

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 27 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website: www.tpicap.com

 

 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

11 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBBLLFLELEBBB
Date   Source Headline
26th Mar 20181:26 pmRNSAllotment of consideration shares
26th Mar 201811:01 amRNSDirector/PDMR Shareholding
14th Mar 20185:19 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
8th Jan 20187:00 amRNSAcquisition
5th Jan 20181:24 pmRNSTotal Voting Rights
5th Jan 20187:00 amRNSNotice of Results
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
8th Dec 201712:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirectorate Change
30th Nov 20177:00 amRNSAcquisition of Coex Partners Limited
30th Nov 20177:00 amRNSCapital Markets Update
29th Nov 20173:45 pmRNSDirector/PDMR Shareholding
23rd Nov 20174:26 pmRNSHolding(s) in Company
22nd Nov 201711:54 amRNSHolding(s) in Company
3rd Nov 20177:00 amRNS3rd Quarter Trading Update
17th Oct 20177:00 amRNSDirectorate Change
5th Oct 20179:58 amRNSHolding(s) in Company
29th Sep 20178:21 amRNSHolding(s) in Company
22nd Sep 20173:58 pmRNSHolding(s) in Company
22nd Sep 201712:28 pmRNSHolding(s) in Company
30th Aug 20173:33 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSFinancial and Interim Management Report
17th Jul 201710:33 amRNSHolding(s) in Company
14th Jul 201712:38 pmRNSHolding(s) in Company
22nd Jun 20179:53 amRNSHolding(s) in Company
16th Jun 201711:37 amRNSHolding(s) in Company
22nd May 20173:02 pmRNSDirector/PDMR Shareholding
15th May 20172:52 pmRNSDirector/PDMR Shareholding
11th May 20174:45 pmRNSResult of Annual General Meeting
11th May 20177:02 amRNSBalance Sheet Strengthens with £270m Bulk Annuity
11th May 20177:00 amRNSAGM Statement and Trading Update
6th Apr 201711:00 amRNSAnnual Financial Report
5th Apr 201711:57 amRNSDirector/PDMR Shareholding
27th Mar 20174:41 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
28th Feb 201712:27 pmRNSNotice of Results
21st Feb 20179:29 amRNSHolding(s) in Company
24th Jan 20176:04 pmRNSTP ICAP GBP 7yr - Post-Stabilisation Notice
24th Jan 20174:42 pmRNSPublication of Final Terms
19th Jan 20175:29 pmRNSIssue of £500m Fixed Rate Senior Unsecured Notes
19th Jan 20178:39 amRNSTP ICAP GBP 7yr - Pre-Stabilisation Notice
18th Jan 201711:03 amRNSPublication of a Prospectus
16th Jan 20176:06 pmRNSHolding(s) in Company
12th Jan 20174:47 pmRNSHolding(s) in Company
12th Jan 20174:42 pmRNSHolding(s) in Company
12th Jan 20174:28 pmRNSHolding(s) in Company
10th Jan 201710:12 amRNSHolding(s) in Company
6th Jan 201710:54 amRNSPublication of a Prospectus
6th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.